Elevai Labs INC 10-Q quarterly reports

PMGC Holdings Inc. files its Q2 2026 Form 10-Q, detailing significant revenue growth from recent acquisitions but also substantial net losses and ongoing going concern uncertainties.

PMGC Holdings Inc. reports significant revenue growth in Q3 2025 driven by recent acquisitions in IT packaging and precision engineering, despite an increased net loss and ongoing going concern doubts.

PMGC Holdings Inc. reports a net loss of $2.17 million for the first six months of 2025, following a strategic pivot from skincare to a diversified holding company with new acquisitions and significant capital raises.

PMGC Holdings Inc. announces its Q1 2025 financial results, highlighting a strategic shift towards diversified investments following the sale of its skincare business.

Elevai Labs Inc. saw a significant increase in revenue and gross profit in the third quarter of 2024, alongside strategic changes in management and operations.

Elevai Labs Inc. saw a significant increase in revenue during the second quarter of 2024, but also experienced substantial losses and challenges to its financial stability.

Elevai Labs Inc. saw a significant increase in revenue during the first quarter of 2024, but also experienced a substantial rise in operating expenses, leading to a net loss.